Patents by Inventor Eva Anne Turley

Eva Anne Turley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of hyaluronic acid and forms to prevent the narrowing of the vascular walls
    Patent number: 6852708
    Abstract: For the prevention of the narrowing of the tubular walls of an animal after the tubular walls have been traumatized, the administration of a therapeutically effective non-toxic amount of a form of Hyaluronic Acid selected from Hyaluronic Acid, salts thereof and combinations thereof to the animal to prevent narrowing of the tubular walls.
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: February 8, 2005
    Assignee: Jagotec AG
    Inventors: Rudolf Edgar Falk, Samuel Simon Ascuali, Eva Anne Turley
  • Use of hyaluronic acid and forms to prevent arterial restenosis
    Patent number: 6022866
    Abstract: A method is provided of inhibiting the narrowing of the vascular tubular walls of an animal by the proliferation of endothelial cells in the area of trauma after the vascular tubular walls have been traumatized, the method comprising the administration of a therapeutically effective non-toxic amount of a form of hyaluronic acid selected from the group consisting of hyaluronic acid and pharmaceutically acceptable salts thereof to the animal to inhibit the narrowing of the vascular tubular walls by the proliferation of endothelial cells into the area of trauma.
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: February 8, 2000
    Assignee: Hyal Pharmaceutical Corporation
    Inventors: Rudolf Edgar Falk, Samuel Simon Asculai, Eva Anne Turley
  • Use of hyaluronic acid and forms to prevent arterial restenosis
    Patent number: 5990095
    Abstract: This invention relates to a method of inhibiting the narrowing of the tubular walls of an animal with a form of hyaluronic acid.
    Type: Grant
    Filed: July 26, 1995
    Date of Patent: November 23, 1999
    Assignee: Hyal Pharmaceutical Corporation
    Inventors: Rudolf Edgar Falk, Samuel Simon Ascuali, Eva Anne Turley
  • Hyaluronic acid and salts thereof inhibit arterial restenosis
    Patent number: 5834444
    Abstract: A method is provided of preventing arterial restenosis of an animal after the arteries have been traumatized. The method comprises the administration of a therapeutically effective non-toxic amount of hyaluronic acid and/or pharmaceutically acceptable salts thereof to the animal to prevent narrowing of the arteries. The form of hyaluronic acid is selected from hyaluronic acid and pharmaceutically acceptable salts thereof having a molecular weight less than 750,000 daltons.
    Type: Grant
    Filed: September 23, 1993
    Date of Patent: November 10, 1998
    Assignee: Hyal Pharmaceutical Corporation
    Inventors: Rudolf Edgar Falk, Eva Anne Turley, Samuel Simon Asculai
  • Treatment of disease and conditions associated with macrophage infiltration
    Patent number: 5767106
    Abstract: A method of treating a human having a disease or condition characterized by macrophage, neutrophile or other white blood cell infiltration into the area damaged by the disease or condition, the method comprising administering to the human an effective amount of hyaluronic acid and/or salts thereof for a period of time until the administration is no longer required.
    Type: Grant
    Filed: August 25, 1994
    Date of Patent: June 16, 1998
    Assignee: Hyal Pharmaceutical Corporation
    Inventors: Eva Anne Turley, Samuel Simon Asculai